You are here: Industry Insights > Pfizer

News List

Trump slams Pfizer over price hikes, Pfizer responds pharmafile
July 17, 2018
Price hiking in the pharmaceutical industry continues to persist, and has become ever more prominent in the public sphere thanks to in part to Donald Trump’s sporadic highlighting of the issue leading up to and throughout his presidency.
Pfizer pulls plug on Inlyta trial pharmatimes
July 17, 2018
Pfizer is terminating a late-stage trial assessing Inlyta in patients at risk of kidney cancer recurrence after an interim analysis showed that it was highly unlikely the drug would offer any benefit in this setting.
Pfizer restructures in preparation for potential sell off pharmafile
July 17, 2018
Pfizer has announced plans to reorganise into three separate units through the separation of its consumer health care business from the other two arms of the company.
Trump forces Pfizer to back down and delay price hikes until 2019 pharmafile
July 17, 2018
Trump bared his teeth, and it paid off. Following his call-out of Pfizer after the US pharma giant ignored the President’s threats to crack down on drug prices and raised the price of 100 of its drugs, the firm has confirmed it will delay planned price hi
FDA expands Pfizer and Astellas' Xtandi into castration-resistant prostate cancer pharmafile
July 17, 2018
Astellas and Pfizer have revealed that their androgen receptor inhibitor Xtandi (enzalutamide) has received approval from the FDA to expand its label indications to include the treatment of metastatic castration-resistant prostate cancer (CRPC).
Pfizer re-organises into three business units pharmatimes
July 16, 2018
Pfizer has announced a re-organisation of its operations into three distinct businesses.
Pfizer's Xeljanz scores EU approval for active psoriatic arthritis pharmafile
July 06, 2018
With the decision, Xeljanz becomes the first and only oral Janus kinase inhibitor to be approved in the European Union (EU) for the treatment of adults with active PsA.
Unfazed by Trump, Pfizer hikes prices for 100 of its drugs pharmafile
July 06, 2018
Undeterred by these proposals, a number of pharma firms have proceeded to simply ignore the lacklustre plans and raise their prices anyway.
Pfizer names winners of Healthcare Hub Challenge pharmatimes
July 04, 2018
Medopad, Perfect Ward and Inhealthcare have been named as this year’s winners of Pfizer’s Healthcare Hub: London challenge.
Pfizer raises prices on 100 drugs, its second round of hikes this year fiercepharma
July 03, 2018
President Trump may think top drugmakers are ready to step up with price cuts, but Pfizer, for one, is going the other way instead.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page